Sie sind auf Seite 1von 22
HENI9727 SLE. -€e. tf a 116TH CONGRESS: | To expand research on the cannabidiol and mariana, IN THE SENATE OF THE UNITED STATES Abs. PEINSTEIN (for herself, Mr. Grassiny, Mr. ScHatz, Mr. DURBIN, Ms. Kropvcnak, Mr. Tr118, Mr. Kaine, Ms, ERNST, and Mr, CRAMER) in- troduced the following bill; which was read tviee and referred to the Com- mittee on A BILL To expand research on the cannabidiol and marihuana. 1 Be it enacted by the Senate and House of Representa- 2 tives of the United States of America in Congress assembled, 3° SECTION 1. SHORT TITLE; TABLE OF CONTENTS. 4 (a) Suorr Trrte.—This Act may be cited as the 5 “Cannabidiol and Marihuana Research Expansion Act”, 6 (b) TABLE OF CONTENTS.—The table of contents for 7 this Act is as follows: See. 1. Shore ttle; table of contents, See, 2. Definitions, ‘TILE T—1W8GISTRATIONS FOR MARINUANA RESEARCH See. 101, Mavilmuans research applications See. 102. Research protocols, See, 103. Applications to manufacture marihuana for research, HEN19727 SLC, Caer aAnann 10 u 12 13 4 15 16 See Seo Sec 1 See See See See. 2 104. Adegnate and wninterrpted supply. 105. Seeurity requirements 106. Prohibition against reinstating interdiseiplinary yeview process for ‘non-NIHT funded researehérs, ITLE I—DEVELOPMENT OF FDA:APPROVED DRUGS Us CANNABIDIOL AND MARIHUANA ie 201, Medica! reewvh on carmahiiol 202, Rouistration for the commervial produetion and distribution of Food ‘nd Drug Administration approved drugs, 203, Importation of eannabidiol for research purposes. ‘TITLE I1K—DOCTOR-PATIENT RELATIONSHIP 301. Doctor-patient relationship. ‘TITLE IV—PEDERAL RESEARCH 401. Peslernl research . 2. DEFINITIONS. In this Act— (1) the term “appropriately registered” means, that an individual or entity is registered under the Controlled Substances Act (21 U.S.C. 801 et seq.) to engage in the type of activity that is earried out by the individual or entity with respect to with a controlled substance on the schedule that is applica ble to cannabidiol or marihuana, as applicable; (2) the term “eannabidiol” means— (A) the substance, cannabidiol, as derived from mariana = that's has a tetrahydrocannabinol level that is greater than 0.3 pereent; and (B) the synthetic equivalent of the sub- stance deseribed in subparagraph (A); HEN19727 Sewmryxanuason u 12 13 14 15 16 7 18 19 20 21 22 23 24 25 3 (3) the terms “controlled substance”, “dis- pense”, “distribute”, “manufacture”, “marihuana”, and “practitioner” have the meanings given such terms in section 102 of the Controlled Substances Act (21 U.S.C, 802), as amended by this Act; (4) the term “covered institution of higher edu- cation” means an institution of higher education (as defined in section 101 of the Higher Education Act of 1965 (20 U.S.C, 1001) that— (A)(i) has highest or higher research activ- ity, as defined by the Carnegie Classification of Institutions of Higher Edueation; or (ii) is an accredited medieal school or an accredited school of osteopathic medicine; and (B) is appropriately registered under the Controlled Substances Act (21 U.S.C. 801 et (5) the term “drug” has the meaning given the term in section 201(g)(1) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321(@)(1)); (6) the term “medical research for drug devel- opment” means medical research that is— (A) a preclinical study or clinical investiga tion conducted in accordance with section 5051 i) of the Federal Food, Drug, and Cos-